Gene signature identifies drivers of treatment resistance in metastatic breast cancer

A multi-institution team of researchers has discovered a genetic signature that can identify drivers of poor outcomes in advanced estrogen-receptor positive (ER+) breast cancer, which could one day lead to personalized treatment for patients.